chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: POSSIBLE FAKE VACCINE CARD OR EXPIRED VACCINE WAS GIVEN; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and expiry: 19-SEP-2021) dose was not reported, administered on 05-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-NOV-2021, the patient experienced possible fake vaccine card or expired vaccine was given. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of possible fake vaccine card or expired vaccine was given was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 05-NOV-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 05-NOV-2021, the patient experienced expired vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: PARTIAL ADMINISTRATION OF VACCINE DUE TO SYRINGE DYSFUNCTION; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced partial administration of vaccine due to syringe dysfunction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of partial administration of vaccine due to syringe dysfunction was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Diplopia, Vision blurred
Clinical narrative: BLURRED VISION; DOUBLE VISION; This spontaneous report received from a patient concerned a 73 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811, expiry: UNKNOWN) dose was not reported, administered on 25-OCT-2021 for prophylactic vaccination. No concomitant medications were reported.  On 26-OCT-2021, the patient experienced blurred vision. On 26-OCT-2021, the patient experienced double vision. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blurred vision, and double vision. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Axillary pain, Diarrhoea, Dysgeusia, Flatulence
Clinical narrative: SHARP PAIN IN STOMACH; LOT OF GAS IN HER SYSTEM; PAIN UNDER ARMPIT; MOTION SICKNESS WHEN DRIVING; DIARRHEA; NAUSEA; METALLIC TASTE; This spontaneous report received from a parent concerned a 22 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811 expiry: UNKNOWN) dose was not reported, administered on 28-OCT-2021 to Right Arm for prophylactic vaccination. No concomitant medications were reported. On 28-OCT-2021, the patient experienced metallic taste. On an unspecified date, the patient experienced sharp pain in stomach, lot of gas in her system, pain under armpit, motion sickness when driving, diarrhea, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from metallic taste on 29-OCT-2021, and had not recovered from sharp pain in stomach, lot of gas in her system, diarrhea, pain under armpit, nausea, and motion sickness when driving. This report was non-serious. This case, from the same reporter is linked to 20211061246.
Sex: F
Vaccine: COVID19
Symptoms: Motion sickness, Nausea
Clinical narrative: SHARP PAIN IN STOMACH; LOT OF GAS IN HER SYSTEM; PAIN UNDER ARMPIT; MOTION SICKNESS WHEN DRIVING; DIARRHEA; NAUSEA; METALLIC TASTE; This spontaneous report received from a parent concerned a 22 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811 expiry: UNKNOWN) dose was not reported, administered on 28-OCT-2021 to Right Arm for prophylactic vaccination. No concomitant medications were reported. On 28-OCT-2021, the patient experienced metallic taste. On an unspecified date, the patient experienced sharp pain in stomach, lot of gas in her system, pain under armpit, motion sickness when driving, diarrhea, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from metallic taste on 29-OCT-2021, and had not recovered from sharp pain in stomach, lot of gas in her system, diarrhea, pain under armpit, nausea, and motion sickness when driving. This report was non-serious. This case, from the same reporter is linked to 20211061246.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: 19-SEP-2021) dose was not reported, administered on 04-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 04-NOV-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Euphoric mood
Clinical narrative: EUPHORIA; This spontaneous report received from a health care professional concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced euphoria. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of euphoria was not reported. This report was non-serious. This case, from the same reporter is linked to 20211114935.
Sex: U
Vaccine: COVID19
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: ADMINISTRATION OF JANSSEN  COVID-19 VACCINE AFTER BEING  PUNCTURED FOR MORE THAN 6HRS; VIAL OF VACCINE PUNCTURED OUTSIDE OF THE 6 HOUR TIME HOUR; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 211A21A, and expiry: 14-DEC-2021) dose was not reported, administered on 05-NOV-2021 for prophylactic vaccination. No concomitant medications were reported.  On 05-NOV-2021, the patient experienced administration of janssen covid-19 vaccine after being punctured for more than 6 hrs. On 05-NOV-2021, the patient experienced vial of vaccine punctured outside of the 6 hour time hour. The action taken with covid-19 vaccine  was not applicable. The outcome of the administration of janssen covid-19 vaccine after being punctured for more than 6hrs and vial of vaccine punctured outside of the 6 hour time hour was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Injection site pruritus, Rash pruritic
Clinical narrative: ITCHY AT THE INJECTION SITE (LEFT ARM); RED RASH ON CHEST THAT IS BURNING/ITCHY; BURNING AT THE INJECTION SITE (LEFT ARM); This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 06-NOV-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 07-NOV-2021, the patient experienced itchy at the injection site (left arm). On 07-NOV-2021, the patient experienced red rash on chest that is burning/itchy. On 07-NOV-2021, the patient experienced burning at the injection site (left arm). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from red rash on chest that is burning/itchy, burning at the injection site (left arm), and itchy at the injection site (left arm). This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Poor quality product administered, Product storage error
Clinical narrative: ADMINISTRATION OF VACCINE FROM A PUNCTURED VIAL AFTER THREE HOURS AT ROOM TEMPERATURE; OUT OF SPECIFICATION PRODUCT USE; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 213D21A, expiry: UNKNOWN) dose was not reported, administered on 05-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-NOV-2021, the patient experienced administration of vaccine from a punctured vial after three hours at room temperature. On 05-NOV-2021, the patient experienced out of specification product use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of vaccine from a punctured vial after three hours at room temperature and out of specification product use was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Pyrexia
Clinical narrative: FELT POORLY THE NEXT DAY, BUT NOT REALLY SICK; CHILLS; HEADACHE; FEVER, THE FOLLOWING NIGHT AFTER VACCINATION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced felt poorly the next day, but not really sick, chills, headache, and fever, the following night after vaccination. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt poorly the next day, but not really sick, chills, headache, and fever, the following night after vaccination. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: BODY ACHES; FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced body aches, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and fever. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Low birth weight baby
Clinical narrative: Lower birth weight; This spontaneous case was reported by a consumer and describes the occurrence of LOW BIRTH WEIGHT BABY (Lower birth weight) in a foetus patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    MEDICAL HISTORY (Parent): The mother's past medical history included Maternal exposure during pregnancy.    No Medical History information was reported.    In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Transplacental) 1 dosage form. On an unknown date, the patient experienced LOW BIRTH WEIGHT BABY (Lower birth weight). At the time of the report, LOW BIRTH WEIGHT BABY (Lower birth weight) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Transplacental) was unknown.       No concomitant medications are provided.  No treatment medications are provided.  3 months post partum the mother and the baby were doing well. No health issues.  This case concerns a foetus of unknown gender and age with no details on relevant medical history, who experienced the unexpected event of Low birth weight baby after transplacental exposure of mRNA- 1273 vaccine / Moderna COVID-19 Vaccine. The mother of the patient received the dose of the vaccine at an unknown stage of gestation and the delivery occurred on an unknown date at an unknown stage of gestation. Very limited information has been provided. The rechallenge is not applicable due to the nature of the event. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.   This case was linked to MOD-2021-364886 (Parent-Child Link).   See case MOD-2021-364886 for details regarding the child case.; Sender's Comments: This case concerns a foetus of unknown gender and age with no details on relevant medical history, who experienced the unexpected event of Low birth weight baby after transplacental exposure of mRNA- 1273 vaccine / Moderna COVID-19 Vaccine. The mother of the patient received the dose of the vaccine at an unknown stage of gestation and the delivery occurred on an unknown date at an unknown stage of gestation. Very limited information has been provided. The rechallenge is not applicable due to the nature of the event. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Vaccination site pain
Clinical narrative: achy; fatigued/felt tired; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (achy), FATIGUE (fatigued/felt tired) and VACCINATION SITE PAIN (sore arm) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced MYALGIA (achy), FATIGUE (fatigued/felt tired) and VACCINATION SITE PAIN (sore arm). At the time of the report, MYALGIA (achy), FATIGUE (fatigued/felt tired) and VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-365922, MOD-2021-365923 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Chills, Diarrhoea, Fatigue
Clinical narrative: Stomach was still feeling uneasy; stomach ache; diarrhea; dry heaving; achiness; a lot vomiting (it was frequent),dry heaving; extreme fatigue; headache; freezing chills; flu-like symptoms; sweatiness; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERHIDROSIS (sweatiness), ABDOMINAL DISCOMFORT (Stomach was still feeling uneasy), ABDOMINAL PAIN UPPER (stomach ache) and DIARRHOEA (diarrhea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Chronic fatigue syndrome since 1985, Chronic interstitial cystitis NOS since 1993, Hypertension since 2019, Chronic back pain since May 2003 and Arthritis since 2007. Concomitant products included HYDROXYZINE for Chronic interstitial cystitis NOS, PARACETAMOL (TYLENOL) for Pain, GABAPENTIN for an unknown indication.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 50 mcg. On 27-Oct-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERHIDROSIS (sweatiness), NAUSEA (dry heaving), MYALGIA (achiness), VOMITING (a lot vomiting (it was frequent),dry heaving), FATIGUE (extreme fatigue), HEADACHE (headache) and CHILLS (freezing chills). On 28-Oct-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach was still feeling uneasy), ABDOMINAL PAIN UPPER (stomach ache) and DIARRHOEA (diarrhea). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (diarrhea), NAUSEA (dry heaving), MYALGIA (achiness), VOMITING (a lot vomiting (it was frequent),dry heaving) and FATIGUE (extreme fatigue) had resolved, HYPERHIDROSIS (sweatiness), HEADACHE (headache) and CHILLS (freezing chills) outcome was unknown and ABDOMINAL DISCOMFORT (Stomach was still feeling uneasy) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication information was provided.   This case was linked to MOD-2021-374828, MOD-2021-374847 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Nov-2021: Significant Follow up received, include race information, new events and medical history
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Influenza like illness, Myalgia, Nausea
Clinical narrative: Stomach was still feeling uneasy; stomach ache; diarrhea; dry heaving; achiness; a lot vomiting (it was frequent),dry heaving; extreme fatigue; headache; freezing chills; flu-like symptoms; sweatiness; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERHIDROSIS (sweatiness), ABDOMINAL DISCOMFORT (Stomach was still feeling uneasy), ABDOMINAL PAIN UPPER (stomach ache) and DIARRHOEA (diarrhea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Chronic fatigue syndrome since 1985, Chronic interstitial cystitis NOS since 1993, Hypertension since 2019, Chronic back pain since May 2003 and Arthritis since 2007. Concomitant products included HYDROXYZINE for Chronic interstitial cystitis NOS, PARACETAMOL (TYLENOL) for Pain, GABAPENTIN for an unknown indication.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 50 mcg. On 27-Oct-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERHIDROSIS (sweatiness), NAUSEA (dry heaving), MYALGIA (achiness), VOMITING (a lot vomiting (it was frequent),dry heaving), FATIGUE (extreme fatigue), HEADACHE (headache) and CHILLS (freezing chills). On 28-Oct-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach was still feeling uneasy), ABDOMINAL PAIN UPPER (stomach ache) and DIARRHOEA (diarrhea). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (diarrhea), NAUSEA (dry heaving), MYALGIA (achiness), VOMITING (a lot vomiting (it was frequent),dry heaving) and FATIGUE (extreme fatigue) had resolved, HYPERHIDROSIS (sweatiness), HEADACHE (headache) and CHILLS (freezing chills) outcome was unknown and ABDOMINAL DISCOMFORT (Stomach was still feeling uneasy) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication information was provided.   This case was linked to MOD-2021-374828, MOD-2021-374847 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Nov-2021: Significant Follow up received, include race information, new events and medical history
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Stomach was still feeling uneasy; stomach ache; diarrhea; dry heaving; achiness; a lot vomiting (it was frequent),dry heaving; extreme fatigue; headache; freezing chills; flu-like symptoms; sweatiness; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERHIDROSIS (sweatiness), ABDOMINAL DISCOMFORT (Stomach was still feeling uneasy), ABDOMINAL PAIN UPPER (stomach ache) and DIARRHOEA (diarrhea) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Chronic fatigue syndrome since 1985, Chronic interstitial cystitis NOS since 1993, Hypertension since 2019, Chronic back pain since May 2003 and Arthritis since 2007. Concomitant products included HYDROXYZINE for Chronic interstitial cystitis NOS, PARACETAMOL (TYLENOL) for Pain, GABAPENTIN for an unknown indication.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 50 mcg. On 27-Oct-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERHIDROSIS (sweatiness), NAUSEA (dry heaving), MYALGIA (achiness), VOMITING (a lot vomiting (it was frequent),dry heaving), FATIGUE (extreme fatigue), HEADACHE (headache) and CHILLS (freezing chills). On 28-Oct-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach was still feeling uneasy), ABDOMINAL PAIN UPPER (stomach ache) and DIARRHOEA (diarrhea). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), ABDOMINAL PAIN UPPER (stomach ache), DIARRHOEA (diarrhea), NAUSEA (dry heaving), MYALGIA (achiness), VOMITING (a lot vomiting (it was frequent),dry heaving) and FATIGUE (extreme fatigue) had resolved, HYPERHIDROSIS (sweatiness), HEADACHE (headache) and CHILLS (freezing chills) outcome was unknown and ABDOMINAL DISCOMFORT (Stomach was still feeling uneasy) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication information was provided.   This case was linked to MOD-2021-374828, MOD-2021-374847 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Nov-2021: Significant Follow up received, include race information, new events and medical history
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 0.25 mL of expired doses were given; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (0.25 mL of expired doses were given) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: Janssen (LOT: 1808609) on 24-Mar-2021. Past adverse reactions to the above products included No adverse event with Janssen.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (0.25 mL of expired doses were given). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (0.25 mL of expired doses were given) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Nov-2021: Follow up received and stated that patient felt fine and with no side effects.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Confusional state, Headache, Inappropriate schedule of product administration, Malaise
Clinical narrative: woke up cold, very cold; not well; Inappropriate schedule of vaccine administered; confused in my  head; arm is hurting/pain in arm; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (confused in my  head), NASOPHARYNGITIS (woke up cold, very cold), MALAISE (not well), VACCINATION SITE PAIN (arm is hurting/pain in arm) and PYREXIA (fever) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939904) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced CONFUSIONAL STATE (confused in my  head), VACCINATION SITE PAIN (arm is hurting/pain in arm), PYREXIA (fever) and HEADACHE (headache). On 28-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 29-Oct-2021, the patient experienced NASOPHARYNGITIS (woke up cold, very cold) and MALAISE (not well). On 28-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, CONFUSIONAL STATE (confused in my  head), NASOPHARYNGITIS (woke up cold, very cold), MALAISE (not well), VACCINATION SITE PAIN (arm is hurting/pain in arm), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2021, Body temperature: 98.7 (High) 98.7.         Patient reports her first dose was Johnson & Johnson (JNJ) - Lot # 1805029 done on 22March2021.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia, Vaccination site pain
Clinical narrative: woke up cold, very cold; not well; Inappropriate schedule of vaccine administered; confused in my  head; arm is hurting/pain in arm; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (confused in my  head), NASOPHARYNGITIS (woke up cold, very cold), MALAISE (not well), VACCINATION SITE PAIN (arm is hurting/pain in arm) and PYREXIA (fever) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939904) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced CONFUSIONAL STATE (confused in my  head), VACCINATION SITE PAIN (arm is hurting/pain in arm), PYREXIA (fever) and HEADACHE (headache). On 28-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 29-Oct-2021, the patient experienced NASOPHARYNGITIS (woke up cold, very cold) and MALAISE (not well). On 28-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, CONFUSIONAL STATE (confused in my  head), NASOPHARYNGITIS (woke up cold, very cold), MALAISE (not well), VACCINATION SITE PAIN (arm is hurting/pain in arm), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2021, Body temperature: 98.7 (High) 98.7.         Patient reports her first dose was Johnson & Johnson (JNJ) - Lot # 1805029 done on 22March2021.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Heart rate, Pyrexia, Vaccination site swelling
Clinical narrative: Arm swollen (near injection site); Slight fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Arm swollen (near injection site)), PYREXIA (Slight fever) and FATIGUE (Fatigue) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Arm swollen (near injection site)), PYREXIA (Slight fever) and FATIGUE (Fatigue). At the time of the report, VACCINATION SITE SWELLING (Arm swollen (near injection site)), PYREXIA (Slight fever) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 85-124 (abnormal) abnormal.         No concomitant medications were provided. No treatment medication were provided. Heart rate is between 85-124 beats per min, how much patient rest.   This case was linked to MOD-2021-368796, MOD-2021-368799 (Patient Link).
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired booster dose of Moderna vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired booster dose of Moderna vaccine) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired booster dose of Moderna vaccine). On 28-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired booster dose of Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Nov-2021: Follow up received , HCP details and  Patient's demographic updated and no ADR for the patient reported.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Limb discomfort, Somnolence
Clinical narrative: After first dose I had wobbly legs; Fatigue; Slept all the day; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (After first dose I had wobbly legs), FATIGUE (Fatigue) and SOMNOLENCE (Slept all the day) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE, VALSARTAN, METOPROLOL SUCCINATE (TOPROL XL), ROSUVASTATIN CALCIUM (CRESTOR OD), OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), FOLIC ACID and ZOLPIDEM TARTRATE (AMBIEN) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (After first dose I had wobbly legs), FATIGUE (Fatigue) and SOMNOLENCE (Slept all the day). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (After first dose I had wobbly legs), FATIGUE (Fatigue) and SOMNOLENCE (Slept all the day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-368875 (Patient Link).
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Rash pruritic
Clinical narrative: whole arm rash itching like crazy; slight fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (whole arm rash itching like crazy), PYREXIA (slight fever) and FATIGUE (fatigue) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 006M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (whole arm rash itching like crazy), PYREXIA (slight fever) and FATIGUE (fatigue). At the time of the report, RASH PRURITIC (whole arm rash itching like crazy), PYREXIA (slight fever) and FATIGUE (fatigue) outcome was unknown.     Concomitant medication use was unknown.  Patient  went to his doctor and got a cream for the rash.   This case was linked to MOD-2021-368796, MOD-2021-368777 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Pain Meds for Vaccination Symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (Pain Meds for Vaccination Symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Pain Meds for Vaccination Symptoms). At the time of the report, VACCINATION COMPLICATION (Pain Meds for Vaccination Symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   There are no treatment and concomitant medications given.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Swelling, Vaccination site erythema, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), SWELLING (swelling), VACCINATION SITE WARMTH (Vaccination site warmth) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Penicillin allergy (Penicillin-rash). Concomitant products included LEVOTHYROXINE and MULTIVITAMIN [VITAMINS NOS] for an unknown indication. In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced ERYTHEMA (redness), SWELLING (swelling), VACCINATION SITE WARMTH (Vaccination site warmth) and VACCINATION SITE ERYTHEMA (Vaccination site erythema). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Pain, at an unspecified dose and frequency. At the time of the report, ERYTHEMA (redness), SWELLING (swelling), VACCINATION SITE WARMTH (Vaccination site warmth) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) had resolved.  This case was linked to MOD-2021-373454 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 02-Nov-2021: Follow up received contains significant information. Patient's race, height and weight, Medical history, Concomitant and treatment medications were added. Events date and outcome were updated.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pyrexia
Clinical narrative: Fever; fatigued; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and FATIGUE (fatigued) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Lung cancer (Immunocompromised). Concomitant products included NIVOLUMAB (OPDIVO), IPILIMUMAB (YERVOY) and PREDNISONE for an unknown indication.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced PYREXIA (Fever) and FATIGUE (fatigued). At the time of the report, PYREXIA (Fever) and FATIGUE (fatigued) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Oct-2021, Body temperature: 101.5 f (High) Patient reported 101.5 F fever.         No treatment information provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Ophthalmic migraine, Pain in extremity
Clinical narrative: ocular migraine on the left side; sore arm; headache; chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of OPHTHALMIC MIGRAINE (ocular migraine on the left side), PAIN IN EXTREMITY (sore arm), HEADACHE (headache), CHILLS (chills) and MYALGIA (body aches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017F21A, 025N21A and 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, the patient experienced OPHTHALMIC MIGRAINE (ocular migraine on the left side). 27-Oct-2021, the patient experienced PAIN IN EXTREMITY (sore arm), HEADACHE (headache), CHILLS (chills) and MYALGIA (body aches). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. On 27-Oct-2021, OPHTHALMIC MIGRAINE (ocular migraine on the left side) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm), HEADACHE (headache), CHILLS (chills) and MYALGIA (body aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included high blood pressure medication  Patient had only 4 episodes of migraine in their lifetime.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 0.25 mL of expired doses were given; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (0.25 mL of expired doses were given) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A, 011M20A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 29-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (0.25 mL of expired doses were given). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (0.25 mL of expired doses were given) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications was reported. Treatment information was not provided.  Most recent FOLLOW-UP information incorporated above includes: On 04-Nov-2021: Follow-up received on 04-NOV-2021 contains No new information.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Pyrexia
Clinical narrative: fever/Fever 101 degrees Farenheight; chills; body aches; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (fever/Fever 101 degrees Farenheight), CHILLS (chills) and MYALGIA (body aches) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and J20-2A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced PYREXIA (fever/Fever 101 degrees Farenheight), CHILLS (chills) and MYALGIA (body aches). In February 2021, PYREXIA (fever/Fever 101 degrees Farenheight), CHILLS (chills) and MYALGIA (body aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 101 (High) Fever 101 degrees Farenheight.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was reported.  Treatment medications was not provided.  It was reported that all symptoms lasted for 1 day.    This case was linked to MOD-2021-368894 (Patient Link).
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, Vomiting
Clinical narrative: I threw up; Fever; Chills; Full body aches; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (I threw up), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Full body aches) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced VOMITING (I threw up), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Full body aches). At the time of the report, VOMITING (I threw up), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Full body aches) outcome was unknown.            No concomitant medication was provided.  No treatment information was provided.   This case was linked to MOD-2021-368918 (Patient Link).
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Toothache, Vaccination site joint pain, X-ray
Clinical narrative: Having tooth pain; sore inside the shoulder joint itself on the left 2 to 3 days; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (Having tooth pain) and VACCINATION SITE JOINT PAIN (sore inside the shoulder joint itself on the left 2 to 3 days) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A, 039A21A and 008C21A) for COVID-19 vaccination.     Concurrent medical conditions included HIV infection.   On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In September 2021, the patient experienced VACCINATION SITE JOINT PAIN (sore inside the shoulder joint itself on the left 2 to 3 days). On an unknown date, the patient experienced TOOTHACHE (Having tooth pain). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Tooth pain, at an unspecified dose and frequency. In September 2021, VACCINATION SITE JOINT PAIN (sore inside the shoulder joint itself on the left 2 to 3 days) had resolved. At the time of the report, TOOTHACHE (Having tooth pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: normal (normal) x-ray was normal.         Patient used HIV antiviral medications.  With the 3rd dose of the vaccine he received the flu and meningitis vaccines simultaneously. He was a little sore inside of the shoulder joint itself on the left for 2-3 days after receiving that dose that resolved without additional treatments. He did not take any additional medications or treatments for that arm.  Patient used 5% lidocaine patch for his right shoulder.   This case was linked to MOD-2021-368949, MOD-2021-368910 (Patient Link).